CVB Share Price Performance
AU$0.08
-0.06 (-40.74%)
46.7% undervalued intrinsic discount
AU$0.15
Fair Value
Price AU$0.08
AnalystConsensusTarget AU$0.15
Fair ValueAU$0.15
Share Pricen/a
CurveBeam AI Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
CVB Community Narratives
AN
Fair Value AU$0.15 46.7% undervalued intrinsic discount
FDA Clearance And AI Advances Will Unlock Future Markets
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
FDA Clearance And AI Advances Will Unlock Future Markets
Key Takeaways Regulatory advancements, AI-driven workflow enhancements, and vendor financing are set to drive revenue growth and expand CurveBeam AI's market reach in healthcare imaging. Diversification across products, applications, geographies, and customer segments decreases risk and supports stable, recurring revenue as orthopedic imaging demand rises.Read more
33
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
AU$0.15
46.7% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
52.26% p.a.
Profit Margin
15.46%
Future PE
11.23x
Price in 2028
AU$0.19
Trending Discussion
Recently Updated Narratives
AN
FDA Clearance And AI Advances Will Unlock Future Markets
Fair Value: AU$0.15 46.7% undervalued intrinsic discount
4 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
CurveBeam AI Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.035
- 44.89%
- -139.24%
- 45.5%
About CVB
- Founded
- 2009
- Employees
- n/a
- CEO
- WebsiteView website
CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.
